Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
Long-term air pollutant exposure, especially with unhealthy habits, increase MAFLD risk
Long-term exposure to ambient air pollutants may increase the risk of metabolic dysfunction-associated fatty liver disease, according to a study published in Journal of Hepatology.
Virtual specialist experience linked to better survival in PCP-treated liver disease
When primary care physicians interact with virtual specialists in hepatology, more of their patients have improved survival rate beyond the initial consultation, according to a presenter at The Liver Meeting Digital Experience.
Log in or Sign up for Free to view tailored content for your specialty!
Gastric bypass, sleeve gastrectomy ‘substantially’ reduce liver fat in type 2 diabetes
Roux-en-Y gastric bypass and sleeve gastrectomy are equally effective at reducing hepatic steatosis, with an almost complete clearance of liver fat 1 year after the surgical procedures, according to data from a single-center study.
VIDEO: Serum creatinine linked to adverse events in HRS-AKI treated with terlipressin
In this exclusive video, Andrew Allegretti, MD, MSc, discussed a post hoc analysis assessing serum creatinine in patients treated with terlipressin for hepatorenal syndrome-acute kidney injury.
VIDEO: Obeticholic acid improves survival in primary biliary cholangitis
In a video exclusive, Gideon Hirschfield, PhD, FRCP, of the University of Toronto, reported the potential of obeticholic acid for improving transplant-free survival among patients with primary biliary cholangitis.
Q&A: Rifaximin plus or minus lactulose reduces ED visits for hepatic encephalopathy
Rifaximin plus or minus lactulose compared with lactulose alone correlated with a decrease in ED health care utilization in patients with hepatic encephalopathy, according to a presentation at the ACG Annual Scientific Meeting.
Undiagnosed anxiety present in 17% of patients with cirrhosis
Using a cirrhosis-centric model, researchers found a high prevalence for anxiety in patients with cirrhosis, according to a presentation at The Liver Meeting Digital Experience.
Pegbelfermin improves markers of fibrosis in NASH
Pegbelfermin was safe and effective in improving markers of steatosis, fibrosis and inflammation among patients with nonalcoholic steatohepatitis with stage 3 fibrosis, according to a presentation at The Liver Meeting Digital Experience.
Increased fatty liver disease awareness needed to mitigate burden among young adults
Increased awareness is needed to mitigate burden fatty liver disease and modifiable risk factors among adolescents and young adults, according to research presented at The Liver Meeting Digital Experience.
FMT restores gut barrier function, improves severe alcohol associated hepatitis outcomes
Improvements in intrahepatic and circulatory inflammation markers were observed after fecal microbiota transplantation in patients with severe alcohol associated hepatitis, according to a presenter at The Liver Meeting Digital Experience.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read